| Smartphone based on-chip fluorescence imaging and capillary flow velocity measurement for detecting ROR1+ cancer cells from buffy coat blood samples on dual-layer paper … TH Ulep, R Zenhausern, A Gonzales, DS Knoff, PAL Diaz, JE Castro, ... Biosensors and Bioelectronics 153, 112042, 2020 | 38 | 2020 |
| Chimeric antigen receptor T cell therapy in oncology–Pipeline at a glance: Analysis of the ClinicalTrials. gov database E Moreno-Cortes, JV Forero-Forero, PA Lengerke-Diaz, JE Castro Critical reviews in oncology/hematology 159, 103239, 2021 | 29 | 2021 |
| Validation of VIRSTA and PREDICT scores to determine the priority of echocardiography in patients with Staphylococcus aureus bacteremia JS Peinado-Acevedo, JJ Hurtado-Guerra, C Hincapié-Osorno, ... Clin Infect Dis 73, e1151-7, 2021 | 29* | 2021 |
| Ibrutinib reduces obinutuzumab infusion-related reactions in patients with chronic lymphocytic leukemia and is associated with changes in plasma cytokine levels JV Lujan, PA Lengerke-Diaz, C Jacobs, EF Moreno-Cortes, ... Haematologica 105 (1), e22, 2020 | 13 | 2020 |
| Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience M Melody, S Gandhi, H Saunders, Z Abdel-Rahman, J Hastings, ... Leukemia & Lymphoma 63 (6), 1363-1368, 2022 | 6 | 2022 |
| C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel M Melody, ZA Rahman, H Saunders, PL Diaz, N Gannon, A Rosenthal, ... Hematology/Oncology and Stem Cell Therapy 14 (2), 141-146, 2021 | 6 | 2021 |
| Chimeric antigen receptor T cell therapy pipeline at a glance: a retrospective and systematic analysis from clinicaltrials. Gov EFM Cortes, CK Stein, PAL Diaz, CA Ramirez-Segura, JE Castro Blood 134, 5629, 2019 | 6 | 2019 |
| Predictors and management of relapse to Axicabtagene Ciloleucel in patients with aggressive B-cell lymphoma JV Forero-Forero, PA Lengerke-Diaz, E Moreno-Cortes, M Melody, ... Hematology/Oncology and Stem Cell Therapy, 2023 | 5 | 2023 |
| Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel M Melody, S Gandhi, ZA Rahman, P Lengerke‐Diaz, N Gannon, ... European Journal of Haematology 107 (1), 48-53, 2021 | 4 | 2021 |
| Ibrutinib plus Obinutuzumab as frontline therapy for chronic lymphocytic leukemia is associated with a lower rate of infusion‐related reactions and with sustained remissions … JE Castro, PA Lengerke-Diaz, J Velez Lujan, MY Choi, EF Moreno-Cortes, ... Advances in Hematology 2022 (1), 4450824, 2022 | 3 | 2022 |
| The Status of Multiple Myeloma in Colombia: First Report of the Colombian Registry for Hemato-Oncological Diseases (RENEHOC). Asociacion Colombiana De Hematologia y Oncologia … V Abello, H Idrobo, CL Sossa, KM Galvez, D Saavedra, MH Solano, ... Blood 132, 5597, 2018 | 3 | 2018 |
| Risk of thrombosis in CAR T-cell therapy recipients M Melody, S Gandhi, H Saunders, Z Abdel-Rahman, J Hastings, PL Diaz, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | 2 | 2021 |
| Long-Term Sustained Responses Following Ibrutinib Discontinuation after Frontline Therapy with Obinutuzumab Plus Ibrutinib in Patients with Chronic Lymphocytic Leukemia PAL Diaz, MY Choi, EFM Cortes, JV Forero, J Velez-Lujan, ... Blood 136, 33-34, 2020 | 2 | 2020 |
| Immune effector cell therapies in oncology: A systematic analysis and forecast from ClinicalTrials. gov. JV Forero-Forero, JE Garcia-Robledo, DA Castro-Martinez, EF Moreno, ... Journal of Clinical Oncology 39 (15_suppl), e14516-e14516, 2021 | 1 | 2021 |
| Baseline Hypoalbuminemia Does Not Appear to Be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (Axi-cel) M Melody, S Gandhi, ZA Rahman, PAL Diaz, N Gannon, AC Rosenthal, ... Blood 134, 5343, 2019 | 1 | 2019 |
| Ibrutinib Reduces Obinutuzumab-Gazyva Infusion Related Reactions (IRR) in Patients with Chronic Lymphocytic Leukemia (CLL) and It Is Associated with Changes on Plasma Cytokine … JV Lujan, C Jacobs, PAL Diaz, EF Moreno-Cortes, CA Ramirez-Segura, ... Blood 132, 1864, 2018 | 1 | 2018 |
| Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia MK Kashyap, H Karathia, D Kumar, RV Alvarez, JV Forero-Forero, ... Molecular Therapy-Nucleic Acids 35 (2), 2024 | | 2024 |
| Dysregulated Spliceosome Activity Involves Increased Intron Retention Plus Upregulation and Phosphorylation of SF3B1 in Chronic Lymphocytic Leukemia MK Kashyap, H Karathia, D Kumar, RV Alvarez, PA Lengerke-Diaz, ... | | 2022 |
| Reply to Karakonstantis, et al; Zervou and Zacharioudakis; and Rasmussen, et al JS Peinado-Acevedo, JJ Hurtado-Guerra, C Hincapié-Osorno, ... Clinical Infectious Diseases 74 (1), 167-168, 2022 | | 2022 |
| Baseline Hypoalbuminemia does not appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-cell Lymphomas Treated with Axicabtagene Ciloleucel (Axi-cel) M Melody, S Gandhi, ZA Rahman, PL Diaz, N Gannon, A Rosenthal, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 248-249, 2020 | | 2020 |
Januario E. Castro, M.D.Mayo Clinic - ArizonaVerified email at mayo.edu
